Wordt geladen...
A Review of the Long-Term Efficacy, Tolerability, and Safety of Exenatide Once Weekly for Type 2 Diabetes
INTRODUCTION: Exenatide once weekly (ExeOW, Bydureon(®), Astra Zeneca), a drug belonging to the class of glucagon-like peptide-1 (GLP-1) receptor agonists, is the first agent approved for treatment of type 2 diabetes (T2D) that can be administered on a weekly basis. METHODS: Data concerning treatmen...
Bewaard in:
| Gepubliceerd in: | Adv Ther |
|---|---|
| Hoofdauteurs: | , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Springer Healthcare
2017
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5565650/ https://ncbi.nlm.nih.gov/pubmed/28674957 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12325-017-0499-6 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|